These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8023141)
1. Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids. Hirschmann R; Smith AB; Taylor CM; Benkovic PA; Taylor SD; Yager KM; Sprengeler PA; Benkovic SJ Science; 1994 Jul; 265(5169):234-7. PubMed ID: 8023141 [TBL] [Abstract][Full Text] [Related]
2. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten. Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032 [TBL] [Abstract][Full Text] [Related]
3. Aspects of antibody-catalyzed primary amide hydrolysis. Titmas RC; Angeles TS; Sugasawara R; Aman N; Darsley MJ; Blackburn G; Martin MT Appl Biochem Biotechnol; 1994; 47(2-3):277-90; discussion 291-2. PubMed ID: 7944343 [TBL] [Abstract][Full Text] [Related]
4. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis. Tantillo DJ; Houk KN J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392 [TBL] [Abstract][Full Text] [Related]
5. A comparison of flexible and constrained haptens in eliciting antibody catalysts for paraoxon hydrolysis. Spivak DA; Hoffman TZ; Moore AH; Taylor MJ; Janda KD Bioorg Med Chem; 1999 Jun; 7(6):1145-50. PubMed ID: 10428386 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies. Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836 [TBL] [Abstract][Full Text] [Related]
7. Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity. Tawfik DS; Zemel RR; Arad-Yellin R; Green BS; Eshhar Z Biochemistry; 1990 Oct; 29(42):9916-21. PubMed ID: 2271630 [TBL] [Abstract][Full Text] [Related]
8. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies. Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184 [TBL] [Abstract][Full Text] [Related]
9. Crystal structures of the free and liganded form of an esterolytic catalytic antibody. Wedemayer GJ; Wang LH; Patten PA; Schultz PG; Stevens RC J Mol Biol; 1997 May; 268(2):390-400. PubMed ID: 9159478 [TBL] [Abstract][Full Text] [Related]
10. Cocaine catalytic antibodies: the primary importance of linker effects. Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477 [TBL] [Abstract][Full Text] [Related]
11. Catalytic antibodies induced by a zwitterionic hapten. Tsumuraya T; Takazawa N; Tsunakawa A; Fleck R; Masamune S Chemistry; 2001 Sep; 7(17):3748-55. PubMed ID: 11575776 [TBL] [Abstract][Full Text] [Related]
12. Racemization during aminolysis of activated esters of N-alkoxycarbonylamino acids by amino acid anions in partially aqueous solvents and a tactic to minimize it. Benoiton NL; Lee YC; Chen FM Int J Pept Protein Res; 1993 May; 41(5):512-6. PubMed ID: 8320044 [TBL] [Abstract][Full Text] [Related]
14. Large rate accelerations in antibody catalysis by strategic use of haptenic charge. Thorn SN; Daniels RG; Auditor MT; Hilvert D Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a catalytic antibody for stereoselective ester hydrolysis--a catalytic residue and mode of product inhibition. Nakatani T; Umeshita R; Hiratake J; Shinzaki A; Suzuki T; Nakajima H; Oda J Bioorg Med Chem; 1994 Jun; 2(6):457-68. PubMed ID: 8000868 [TBL] [Abstract][Full Text] [Related]
16. Antibody-catalyzed degradation of cocaine. Landry DW; Zhao K; Yang GX; Glickman M; Georgiadis TM Science; 1993 Mar; 259(5103):1899-901. PubMed ID: 8456315 [TBL] [Abstract][Full Text] [Related]
17. Remarkable remote chiral recognition in a reaction mediated by a catalytic antibody. D'Souza LJ; Gigant B; Knossow M; Green BS J Am Chem Soc; 2002 Mar; 124(10):2114-5. PubMed ID: 11878955 [TBL] [Abstract][Full Text] [Related]
18. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens. Odenbaugh AL; Helms ED; Iverson BL Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164 [TBL] [Abstract][Full Text] [Related]
19. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis. Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271 [TBL] [Abstract][Full Text] [Related]
20. Substrate specificity of the amino acyl adenylate activation sites of gramicidin S-synthetase (GSS). Vater J; Kleinkauf H Acta Microbiol Acad Sci Hung; 1975; 22(4):419-25. PubMed ID: 58543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]